- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
Patent holdings for IPC class C07K 14/315
Total number of patents in this class: 851
10-year publication summary
|
60
|
52
|
70
|
59
|
49
|
45
|
50
|
61
|
56
|
43
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Oxford University Innovation Limited | 1537 |
22 |
| Novartis AG | 10744 |
20 |
| Affibody AB | 115 |
16 |
| Glaxosmithkline Biologicals S.A. | 1651 |
15 |
| Children's Medical Center Corporation | 1876 |
14 |
| The Regents of the University of California | 19961 |
13 |
| President and Fellows of Harvard College | 5986 |
13 |
| Kaneka Corporation | 4534 |
11 |
| Griffith University | 155 |
11 |
| Intervacc AB | 16 |
11 |
| The Trustees of the University of Pennsylvania | 4323 |
8 |
| Minervax ApS | 11 |
8 |
| St. Jude Children's Research Hospital | 242 |
8 |
| Chr. Hansen A/S | 1058 |
8 |
| International N&h Denmark ApS | 340 |
8 |
| Wyeth LLC | 659 |
7 |
| The General Hospital Corporation | 4740 |
7 |
| Duke University | 3069 |
7 |
| DuPont Nutrition Biosciences ApS | 476 |
7 |
| Bioatla, Inc. | 106 |
7 |
| Other owners | 630 |